TABLE OF CONTENTS 2 bl f C Table of Contents bl f C NOTE REGARDING FORWARD–LOOKING STATEMENTS This Annual Report on Form 10-K may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified using forward-looking terminology, including the terms "believes", "estimates", "anticipates, "expects", "seeks", "projects", "intends", plans," "may", "will" or "should" or, in each case, their negative or o ...

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q4 2022 Earnings Conference Call March 14, 2023 8:00 AM ET Company Participants Ravi Jani - Vice President of Investor Relations Rob Wiesenthal - Founder and Chief Executive Officer Will Heyburn - Chief Financial Officer Conference Call Participants Jason Helfstein - Oppenheimer Bill Peterson - J.P. Morgan Hillary Cacanando - Deutsche Bank Stephen Ju - Credit Suisse Itay Michaeli - Citi Operator Good day, ladies and gentlemen, and welcome to the Blade Air Mobility Fisc ...

BLADE March 2023 FORWARD LOOKING STATEMENTS Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Blade's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: our continued incurrence of significant losses; th ...

Financial Performance - Total revenue for the three months ended September 30, 2022, reached $45.7 million, a 125% increase from $20.3 million in 2021[218]. - Revenue for the nine months ended September 30, 2022, increased by $65.5 million or 154%, from $42.5 million in 2021 to $108.0 million in 2022[232]. - MediMobility Organ Transport revenue surged by $18.0 million, an 801% increase from $2.2 million in 2021 to $20.2 million in 2022, attributed to the acquisition of Trinity and growth in trip volume and pricing[220]. - Short Distance revenue increased by $7.0 million, a 52% rise from $13.4 million in 2021 to $20.4 million in 2022, driven by price increases, the acquisition of Blade Europe, and the launch of Blade Canada[219]. - MediMobility Organ Transport revenue increased by $45.0 million or 877% from $5.1 million in 2021 to $50.1 million in 2022[234]. - Short Distance revenue increased by $15.3 million or 76% from $20.3 million in 2021 to $35.6 million in 2022[233]. - Jet and Other revenue increased by $0.4 million in 2022, an increase of 9%, from $4.7 million in 2021 to $5.1 million[221]. Operational Metrics - In the three months ended September 30, 2022, the total number of seats flown for all passenger flights was 28,440, a significant increase from 13,897 in the same period of 2021, representing a growth of approximately 104%[187]. - The company reported a total of 75,175 seats flown in the nine months ended September 30, 2022, compared to 22,123 in the same period of 2021, marking an increase of approximately 239%[187]. - The company’s MediMobility Organ Transport service continued to see increasing demand throughout the COVID-19 pandemic, contrasting with the decline in Short Distance passenger services[188]. Acquisitions and Expansion - The company completed the acquisition of Trinity Air Medical, Inc. on September 15, 2021, enhancing its organ transport capabilities across 16 states[166]. - On September 1, 2022, the company acquired Héli Tickets France and Helicopter Monaco for €47.8 million ($48.1 million), expanding its operations into the European market[168][176]. - The company is focused on expanding into dense urban areas with existing air transportation infrastructure to enhance service efficiency and reduce congestion[197]. Cost and Expenses - Operating expenses totaled $56.2 million for the three months ended September 30, 2022, compared to $30.0 million in 2021, reflecting increased costs across various categories[215]. - Cost of revenue increased by $20.6 million, or 130%, from $15.9 million in 2021 to $36.5 million in 2022, driven by increased flight volume and higher average trip prices[222]. - General and administrative expenses increased by $3.7 million, or 31%, from $12.1 million in 2021 to $15.8 million in 2022[227]. - General and administrative expenses for the nine months ended September 30, 2022, increased by $15.2 million, or 57%, from $26.7 million in 2021 to $41.9 million in 2022[242]. - Selling and marketing expenses increased by $0.6 million, or 51%, from $1.2 million during 2021 to $1.9 million in 2022[229]. - Selling and marketing expenses increased by $2.9 million, or 118%, from $2.4 million in 2021 to $5.3 million in 2022, primarily due to higher marketing spend and increased staff costs[247]. Cash Flow and Financial Position - Net cash used in operating activities was $28.0 million for the nine months ended September 30, 2022, compared to $15.6 million in the same period of 2021, marking a 79% increase[261]. - Net cash provided by investing activities was $78.9 million for the nine months ended September 30, 2022, driven by $248.4 million from the sale of short-term investments[264]. - As of September 30, 2022, the company had cash and cash equivalents of $51.8 million, up from $2.6 million as of December 31, 2021[254]. - The company anticipates that its available cash and cash equivalents and short-term investments will be sufficient to meet operational needs for at least the next 12 months[254]. - The company expects to incur net losses in the short term while executing strategic initiatives, with a net loss of $11.8 million for the nine months ended September 30, 2022[255]. Strategic Initiatives and Future Outlook - The company anticipates leveraging Electric Vertical Aircraft (EVA) technology to reduce operating costs and enhance service offerings in the future[185]. - The company’s business model is designed to transition smoothly to EVA, which is expected to lower consumer prices and reduce carbon emissions[185]. - The development and approval of Electric Vertical Aircraft (EVA) for passenger travel are anticipated to lower operating costs and facilitate new vertiports, although FAA certification is still pending[201]. - The company plans to continue significant investments in attracting new fliers and expanding service offerings, which may not guarantee immediate sales growth or profits[193]. - Inflation impacts are a concern, as costs paid to third-party operators are subject to annual renegotiation and may affect pricing strategies in the future[196]. Impact of COVID-19 - The company experienced a significant impact from the Omicron variant on Short Distance services during Q1 2022, but recovery trends aligned with typical seasonality resumed in 2022[203]. - The company has implemented safety measures during the COVID-19 pandemic that did not materially increase costs, while also reducing the number of Short Distance flights offered[189].

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Ravi Jani - VP, IR Robert Wiesenthal - Founder and CEO William Heyburn - CFO Conference Call Participants Jason Helfstein - Oppenheimer Hillary Cacanando - Deutsche Bank Stephen Ju - Credit Suisse Operator Good day, and thank you for standing by. Welcome to the Blade Air Mobility Inc. Fiscal Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After ...

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Ravi Jani - VP, IR Robert Wiesenthal - CEO & Director Melissa Tomkiel - President William Heyburn - CFO & Head, Corporate Development Conference Call Participants Hillary Cacanando - Deutsche Bank Stephen Ju - Crédit Suisse William Peterson - JPMorgan Chase & Co. Jason Helfstein - Oppenheimer Itay Michaeli - Citigroup Operator Good morning, and welcome to the Blade Urban Air Mobility Inc. F ...

Table of Contents bl f C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-39046 BLADE AIR MOBILITY, INC. | --- | --- | --- | --- | --- | |-------------------------------------- ...

Investor Presentation – May 10, 2022 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "anticipate", "believe", "could", "continue", "expect", "estimate", "may", "plan", "outlook", "scheduled," "future" and "project" and other similar expres ...

Table of Contents bl f C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-39046 BLADE AIR MOBILITY, INC. | --- | --- | --- | --- | --- | |------------------------------------- ...

Financial Data and Key Metrics Changes - Revenues for Q4 2021 increased by 208% to $24.6 million compared to $8 million in Q4 2020, and increased by 371% compared to $5.2 million in Q4 2019 [7] - Full calendar year revenues for 2021 were $67.2 million, up 156% from 2020 and up 106% from pre-COVID 2019 [8] - Flight profit for Q4 2021 increased by 146% to $4 million compared to $1.6 million in Q4 2020, and was negative $0.6 million in Q4 2019 [7] Business Line Data and Key Metrics Changes - Short Distance revenues increased by 191% to $6.2 million in Q4 2021 compared to $2.1 million in Q4 2020 [15] - MediMobility Organ Transport and Jet revenues increased by 227% to $18 million in Q4 2021 compared to $5.5 million in Q4 2020 [16] - Flight margin decreased to 16% in Q4 2021 from 20% in Q4 2020, primarily due to the relaunch of BLADE Airport service [17] Market Data and Key Metrics Changes - The company has seen a limited impact from the Omicron variant on its BLADE Airport and Vancouver businesses in Q1 2022 [22] - The annualized passenger run rate for BLADE Airport dropped to approximately 5,000 in early January but has since doubled to about 10,000 [24] Company Strategy and Development Direction - The company is focused on expanding and diversifying its services and geographies, with a strong emphasis on MediMobility and Jet divisions [10][14] - The transition to Electric Vertical Aircraft (EVA) is a key strategic goal, with ongoing partnerships to enhance technology and infrastructure [12][26] - The company aims to leverage its asset-light model to quickly adapt to market opportunities, particularly in the Northeast [30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery of travel demand as mask mandates are lifted and workers return to offices [23] - The company does not expect a material impact on revenues in Q1 2022 despite the Omicron outbreak [11] - Management highlighted the strong growth potential in the MediMobility business, which is expected to continue benefiting from synergies with the retail business [34][52] Other Important Information - General and administrative expenses increased significantly due to corporate overhead costs and public company-related expenses [19] - The company is actively monitoring the situation regarding potential flight restrictions in East Hampton and is prepared to adapt its operations accordingly [41] Q&A Session Summary Question: Updates on Short Distance revenues and LaGuardia service - Management sees a huge market opportunity in connecting Northeast cities and plans to restart LaGuardia service when conditions are favorable [30][31] Question: Growth expectations for MediMobility versus Airport services - MediMobility is expected to contribute the majority of revenues, with strong growth driven by synergies with the retail business [34] Question: Expansion plans for the West Coast and Miami - The company is being opportunistic about expanding to the West Coast and sees potential growth in Miami due to increased demand from New York transplants [36][50] Question: Impact of rising fuel costs on margins - Management does not expect rising fuel costs to materially impact margins, as fuel is a small portion of overall trip costs [46] Question: Insights on hybrid business-leisure travel trends - The company has observed an increase in leisure travelers using BLADE Airport, which has positively impacted overall demand [45]